G.ST Antivirals

About:

G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals against infections of the respiratory tract.

Website: https://www.gst-antivirals.com/

Top Investors: xista science ventures, Lansdowne Partners

Description:

G.ST Antivirals is a clinical-stage biotech company that applies an innovative host cell-based strategy to develop broad-spectrum antivirals against infections of the respiratory tract.

Total Funding Amount:

8.7M EUR

Headquarters Location:

Vienna, Wien, Austria

Founded Date:

2019-10-01

Contact Email:

office(AT)gst-antivirals.com

Founders:

Guido Gualdoni, Johannes Stöckl

Number of Employees:

11-50

Last Funding Date:

2024-01-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai